Catechins Market To Exceed Valuation Of US$ 30.5 Mn By 2032- FMI NEWARK, Del, May 04, 2022 (GLOBE NEWSWIRE) -- Total demand in the global catechins market is slated to surge at a 5.7% CAGR, reaching US$ 30.5 Mn by 2032. Catechins are extensively used in...

Plandai Biotechnology Discusses Cannabis Strategy, Research and Business LONDON, UNITED KINGDOM , April 19, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), a producer of nutraceutical and highly phyto-available...

Plandaí Biotechnology's Upcoming Clinical Trial Could Strengthen Case for Phytofare in Treatment of Diabetes NEW YORK, NY--(Marketwired - May 18, 2017) - Plandaí Biotechnology (OTCQB: PLPL) announced that it will conduct a human clinical trial to study the effectiveness of using its highly bioavailable...

Plandai Biotechnology's Production Facility Is an Intricate Maze of Proprietary Equipment Producing an Unmistakable Green Tea Extract NEW YORK, NY--(Marketwired - April 02, 2015) - After years of hard work, Plandaí Biotechnology (OTCQB: PLPL) has everything in place to start realizing the long-time dream of the company's CEO Roger...

Plandai Biotechnology Producing a More Potent Product Than First Reported NEW YORK, NY--(Marketwired - March 09, 2015) - Plandaí Biotechnology (OTCQB: PLPL) has probably chosen to err on the side of "under promise and over deliver" when it comes to the bioavailability of...